Literature DB >> 11588899

Coffee and alcohol intake and risk of ovarian cancer: an Italian case-control study.

A Tavani1, S Gallus, L Dal Maso, S Franceschi, M Montella, E Conti, C La Vecchia.   

Abstract

The relation between coffee and alcohol intake and ovarian cancer risk was analyzed in a case-control study conducted in Italy between 1992 and 1999. Cases were 1,031 women, aged 18-79 years, with incident, histologically confirmed invasive epithelial ovarian cancer, and controls were 2,411 women, aged 17-79 years, admitted to the hospital for acute nonneoplastic non-hormone-related diseases. Coffee intake (mostly espresso and mocha) was not associated with ovarian cancer risk, with an odds ratio (OR) of 0.93 [95% confidence interval (CI) = 0.69-1.27] in drinkers of > or = 4 cups/day compared with drinkers of < 1 cup/day. No meaningful relation was observed with cappuccino (OR = 1.06, 95% CI = 0.85-1.32 for drinkers compared with nondrinkers), decaffeinated coffee (OR = 0.64, 95% CI 0.42-0.96), and tea intake (OR = 0.90, 95% CI = 0.75-1.08). Total alcohol intake was not associated with ovarian cancer risk (OR = 1.09, 95% CI = 0.76-1.57 in drinkers of > or = 36 g/day compared with never drinkers). No relationship was found with wine (OR = 1.03, 95% CI = 0.70-1.50 for > 39 g/day compared with never drinkers), beer, amari, grappa, and spirits. No significant heterogeneity was found for coffee or total alcohol intake across strata of age, education, parity, oral contraceptive use, family history of ovarian/breast cancer, body mass index, and calorie intake. This study, based on a large data set; provides no support for a causal association between invasive epithelial ovarian cancer risk and coffee and alcohol intake.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11588899     DOI: 10.1207/S15327914nc391_4

Source DB:  PubMed          Journal:  Nutr Cancer        ISSN: 0163-5581            Impact factor:   2.900


  8 in total

1.  Wine drinking and epithelial ovarian cancer risk: a meta-analysis.

Authors:  Hee Seung Kim; Jae Weon Kim; Leo J Shouten; Susanna C Larsson; Hyun Hoon Chung; Yong Beom Kim; Woong Ju; Noh Hyun Park; Yong Sang Song; Seung Cheol Kim; Soon-Beom Kang
Journal:  J Gynecol Oncol       Date:  2010-06-30       Impact factor: 4.401

2.  Folate, vitamin B(6) , vitamin B(12) , methionine and alcohol intake in relation to ovarian cancer risk.

Authors:  Holly R Harris; Daniel W Cramer; Allison F Vitonis; Mary DePari; Kathryn L Terry
Journal:  Int J Cancer       Date:  2011-11-08       Impact factor: 7.396

Review 3.  Green and black tea in relation to gynecologic cancers.

Authors:  Lesley M Butler; Anna H Wu
Journal:  Mol Nutr Food Res       Date:  2011-05-19       Impact factor: 5.914

4.  Coffee and caffeine intake and the risk of ovarian cancer: the Iowa Women's Health Study.

Authors:  Natalie A Lueth; Kristin E Anderson; Lisa J Harnack; Jayne A Fulkerson; Kim Robien
Journal:  Cancer Causes Control       Date:  2008-08-14       Impact factor: 2.506

5.  Flavonoid intake and ovarian cancer risk in a population-based case-control study.

Authors:  Margaret A Gates; Allison F Vitonis; Shelley S Tworoger; Bernard Rosner; Linda Titus-Ernstoff; Susan E Hankinson; Daniel W Cramer
Journal:  Int J Cancer       Date:  2009-04-15       Impact factor: 7.396

6.  Wine and other alcohol consumption and risk of ovarian cancer in the California Teachers Study cohort.

Authors:  Ellen T Chang; Alison J Canchola; Valerie S Lee; Christina A Clarke; David M Purdie; Peggy Reynolds; Leslie Bernstein; Daniel O Stram; Hoda Anton-Culver; Dennis Deapen; Harvey Mohrenweiser; David Peel; Rich Pinder; Ronald K Ross; Dee W West; William Wright; Argyrios Ziogas; Pamela L Horn-Ross
Journal:  Cancer Causes Control       Date:  2007-02       Impact factor: 2.506

7.  Tea consumption and the risk of ovarian cancer: A meta-analysis of epidemiological studies.

Authors:  Xin Zhan; Jie Wang; Shufen Pan; Caijuan Lu
Journal:  Oncotarget       Date:  2017-06-06

8.  Tea and coffee drinking and ovarian cancer risk: results from the Netherlands Cohort Study and a meta-analysis.

Authors:  J Steevens; L J Schouten; B A J Verhage; R A Goldbohm; P A van den Brandt
Journal:  Br J Cancer       Date:  2007-10-09       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.